Munich (DE) – The development of advanced and personalized therapies, such as Cell & Gene Therapies (also called Advanced Therapy Medicinal Products, ATMPs), brings with it a complexity of patient-specific processes as well as numerous stakeholders, that requires new collaboration paradigms. For this reason, SAP and Hypertrust Patient Data Care (HPDC) have worked closely… Continue reading Discover how SAP & HPDC used cross-company business workflow to improve transparency in personalized cancer therapies and clinical trials